CD127 / Janelia Fluor 669 / lusvertikimab

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP3-28021JF669 (View supplier product page)
Size 100 μl
Price $379.00
Antigen CD127
Clone lusvertikimab
Host Human
Isotype IgG4
Conjugate Janelia Fluor 669
Target Species Human
Applications FC, ELISA, Functional
Description IL-7R alpha/CD127 Antibody (lusvertikimab) [Janelia Fluor® 669]
About CD127 and Janelia Fluor 669
CD127 The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
Janelia Fluor 669 Janelia Fluor® 669 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 669 has an excitation peak at 669 nm and an emission peak at 682 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 669 Excitation and Emission Spectra